Omega Pharma Closes Acquisition Deal for Inpha 2000
Deal News | Dec 17, 2024 | Legal Community Italy
Omega Pharma, affiliated with 21 Invest, has successfully acquired Inpha 2000, a prominent Italian company in the nutraceutical industry, noted for its expertise in research, development, and commercialisation of nutraceutical products. The acquisition process was supported by various legal and financial advisory firms, including PedersoliGattai, Russo De Rosa Associati, and Pavia e Ansaldo. Omega Pharma received legal assistance from PedersoliGattai, with particular focus on finance, antitrust, and due diligence matters. Russo De Rosa Associati provided guidance on tax and structuring aspects. Inpha 2000, represented by Pavia e Ansaldo for legal and company matters, will continue to see involvement from its founders in the holding company shareholding, while the current CEO, Marco Pratesi, will retain his position. Meanwhile, Orrick represented the banks involved in financing aspects of the deal.
Sectors
- Nutraceuticals
- Legal Services
Geography
- Italy – The acquisition involves Omega Pharma and Inpha 2000, both of which are based in Italy, as well as Italian legal advisory firms.
Industry
- Nutraceuticals – Both Omega Pharma and Inpha 2000 operate within the nutraceutical industry, focusing on the research, development, and commercialization of nutraceutical products.
- Legal Services – Various legal firms such as PedersoliGattai, Russo De Rosa Associati, Pavia e Ansaldo, and Orrick played a significant role in advising on legal, financial, and structural aspects of the acquisition.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Omega Pharma | Buyer | Company | A company active in the nutraceutical sector and associated with 21 Invest. |
| Inpha 2000 | Target | Company | An Italian company specializing in research, development, and commercialization of nutraceuticals. |
| Pavia e Ansaldo | Legal Advisor for Inpha 2000 | Company | The legal firm that advised Inpha 2000 on legal and corporate matters related to the acquisition. |
| PedersoliGattai | Lead Legal Advisor for Omega Pharma | Company | Provided legal assistance to Omega Pharma throughout the acquisition, including finance, antitrust, and due diligence. |
| Russo De Rosa Associati | Tax and Structuring Advisor for Omega Pharma | Company | Assisted Omega Pharma with tax-related and structural aspects of the acquisition. |
| Orrick | Legal Advisor for Financing | Company | Advised the financing banks on legal matters related to the acquisition. |
| Giuseppe Samaritani | Founder of Inpha 2000 | Person | Co-founder who will join the holding company's shareholding. |
| Simone Castelli | Founder of Inpha 2000 | Person | Co-founder who will join the holding company's shareholding. |
| Marco Pratesi | CEO of Inpha 2000 | Person | Will continue to serve as CEO of Inpha 2000 post-acquisition. |